Tyrosine-KinaseInhibitorMastodyniaDefinitiveSurgeryPARPInhibitorsGeneMutationMegestrolAcetateBilateralProphylacticMastectomyStagingLumpectomyGeneticPredispositionRelapseCystMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltSelf-examinationFlowCytometryGeneticCounselingBrachytherapyChemopreventionDown-StagingGuaranteedRenewableInsuranceProgestinCytotoxicMethotrexateDoseDenseTherapyOligometastasesBRCAGeneER+/-HormoneReceptorStatusPalpationSERMAbsoluteRiskEstrogen/EstradiolLumpHerceptinEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearAyurvedaTamoxifenCDK4/6InhibitorsMultimodalityTherapyBiopsyAdjuvantTherapyPagetDiseaseCheckpointInhibitorMastectomyMultifocalTumorsAntibodyTherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyTriple +/-BreastCancerChemotherapyDimplingIntraductalPapillomaMetastasisGermlineMutationAdvocacyMRIRaloxifeneCalcificationsWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.DoxorubicinAromataseInhibitorsNeoadjuvantTherapyCachexiaFISHPathologicResponseBevacizumabDocetaxelPaclitaxelAngiogenesisPrecisionMedicineCo-survivorGailModelECOGScore5-FluorouracilAdenocarcinomaKappaEpsilonHormoneReplacementTherapyBI-RADSBreastCancerRadiotherapyKi-67RateFibroadenomaCMFChemotherapyPalbociclibMorpheaCytostaticImmunotherapyPhysicalactivity mayreduce therisk of breastcancersCAMApoptosisIn-situCarcinomaHER-2TumorGradeLCISEGFRmTORInhibitorsACChemotherapyPhyllodesTumorAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenAlopeciaFamilyHistoryBreastTomosynthesisLymphoscintigraphyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55LymphNodeStatusCapecitabineFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AntiemeticsCyclophosphamideLapatinibBOCAAnastrozolePI3KinaseInhibitorsRADAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancer1 in 8womenOvarianSuppressionTyrosine-KinaseInhibitorMastodyniaDefinitiveSurgeryPARPInhibitorsGeneMutationMegestrolAcetateBilateralProphylacticMastectomyStagingLumpectomyGeneticPredispositionRelapseCystMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltSelf-examinationFlowCytometryGeneticCounselingBrachytherapyChemopreventionDown-StagingGuaranteedRenewableInsuranceProgestinCytotoxicMethotrexateDoseDenseTherapyOligometastasesBRCAGeneER+/-HormoneReceptorStatusPalpationSERMAbsoluteRiskEstrogen/EstradiolLumpHerceptinEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearAyurvedaTamoxifenCDK4/6InhibitorsMultimodalityTherapyBiopsyAdjuvantTherapyPagetDiseaseCheckpointInhibitorMastectomyMultifocalTumorsAntibodyTherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyTriple +/-BreastCancerChemotherapyDimplingIntraductalPapillomaMetastasisGermlineMutationAdvocacyMRIRaloxifeneCalcificationsWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.DoxorubicinAromataseInhibitorsNeoadjuvantTherapyCachexiaFISHPathologicResponseBevacizumabDocetaxelPaclitaxelAngiogenesisPrecisionMedicineCo-survivorGailModelECOGScore5-FluorouracilAdenocarcinomaKappaEpsilonHormoneReplacementTherapyBI-RADSBreastCancerRadiotherapyKi-67RateFibroadenomaCMFChemotherapyPalbociclibMorpheaCytostaticImmunotherapyPhysicalactivity mayreduce therisk of breastcancersCAMApoptosisIn-situCarcinomaHER-2TumorGradeLCISEGFRmTORInhibitorsACChemotherapyPhyllodesTumorAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenAlopeciaFamilyHistoryBreastTomosynthesisLymphoscintigraphyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55LymphNodeStatusCapecitabineFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AntiemeticsCyclophosphamideLapatinibBOCAAnastrozolePI3KinaseInhibitorsRADAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancer1 in 8womenOvarianSuppression

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. Tyrosine-Kinase Inhibitor
  2. Mastodynia
  3. Definitive Surgery
  4. PARP Inhibitors
  5. Gene Mutation
  6. Megestrol Acetate
  7. Bilateral Prophylactic Mastectomy
  8. Staging
  9. Lumpectomy
  10. Genetic Predisposition
  11. Relapse
  12. Cyst
  13. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  14. Self-examination
  15. Flow Cytometry
  16. Genetic Counseling
  17. Brachytherapy
  18. Chemoprevention
  19. Down-Staging
  20. Guaranteed Renewable Insurance
  21. Progestin
  22. Cytotoxic
  23. Methotrexate
  24. Dose Dense Therapy
  25. Oligometastases
  26. BRCA Gene
  27. ER +/-
  28. Hormone Receptor Status
  29. Palpation
  30. SERM
  31. Absolute Risk
  32. Estrogen/Estradiol
  33. Lump
  34. Herceptin
  35. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  36. Ayurveda
  37. Tamoxifen
  38. CDK4/6 Inhibitors
  39. Multimodality Therapy
  40. Biopsy
  41. Adjuvant Therapy
  42. Paget Disease
  43. Checkpoint Inhibitor
  44. Mastectomy
  45. Multifocal Tumors
  46. Antibody Therapy
  47. Women ages 40+ should have a clinical breast exam at least yearly
  48. Triple +/- Breast Cancer
  49. Chemotherapy
  50. Dimpling
  51. Intraductal Papilloma
  52. Metastasis
  53. Germline Mutation
  54. Advocacy
  55. MRI
  56. Raloxifene
  57. Calcifications
  58. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  59. Doxorubicin
  60. Aromatase Inhibitors
  61. Neoadjuvant Therapy
  62. Cachexia
  63. FISH
  64. Pathologic Response
  65. Bevacizumab
  66. Docetaxel
  67. Paclitaxel
  68. Angiogenesis
  69. Precision Medicine
  70. Co-survivor
  71. Gail Model
  72. ECOG Score
  73. 5-Fluorouracil
  74. Adenocarcinoma
  75. Kappa Epsilon
  76. Hormone Replacement Therapy
  77. BI-RADS
  78. Breast Cancer
  79. Radiotherapy
  80. Ki-67 Rate
  81. Fibroadenoma
  82. CMF Chemotherapy
  83. Palbociclib
  84. Morphea
  85. Cytostatic
  86. Immunotherapy
  87. Physical activity may reduce the risk of breast cancers
  88. CAM
  89. Apoptosis
  90. In-situ Carcinoma
  91. HER-2
  92. Tumor Grade
  93. LCIS
  94. EGFR
  95. mTOR Inhibitors
  96. AC Chemotherapy
  97. Phyllodes Tumor
  98. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  99. Alopecia
  100. Family History
  101. Breast Tomosynthesis
  102. Lymphoscintigraphy
  103. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  104. Lymph Node Status
  105. Capecitabine
  106. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  107. Antiemetics
  108. Cyclophosphamide
  109. Lapatinib
  110. BOCA
  111. Anastrozole
  112. PI3 Kinase Inhibitors
  113. RAD
  114. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  115. 1 in 8 women
  116. Ovarian Suppression